Department of Laboratory Medicine, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, China.
J Extracell Vesicles. 2022 Nov;11(11):e12281. doi: 10.1002/jev2.12281.
Extracellular vesicles (EVs) have found diverse applications in clinical theranostics. However, the current techniques to isolate plasma EVs suffer from burdensome procedures and limited yield. Herein, we report a rapid and efficient EV isolation platform, namely, EV-FISHER, constructed from the metal-organic framework featuring cleavable lipid probes (PO -spacer-DNA-cholesterol, PSDC). The EV-FISHER baits EVs from plasma by cholesterol and separates them with an ordinary centrifuge. The captured EVs could be released and collected upon subsequent cleavage of PSDC by deoxyribonuclease I. We conclude that EV-FISHER dramatically outperforms the ultracentrifugation (UC) in terms of time (∼40 min vs. 240 min), isolation efficiency (74.2% vs. 18.1%), and isolation requirement (12,800 g vs. 135,000 g). In addition to the stable performance in plasma, EV-FISHER also exhibited excellent compatibility with downstream single-EV flow cytometry, enabling the identification of glypican-1 (GPC-1) EVs for early diagnosis, clinical stages differentiation, and therapeutic efficacy evaluation in breast cancer cohorts. This work portrays an efficient strategy to isolate EVs from complicated biological fluids with promising potential to facilitate EVs-based theranostics.
细胞外囊泡 (EVs) 在临床治疗学中有广泛的应用。然而,目前从血浆中分离 EVs 的技术存在操作繁琐和产量有限的问题。在此,我们报告了一种快速有效的 EV 分离平台,即 EV-FISHER,它由具有可裂解脂质探针(PO-spacer-DNA-胆固醇,PSDC)的金属有机骨架构建而成。EV-FISHER 通过胆固醇从血浆中捕获 EVs,并通过普通离心机将其分离。随后通过脱氧核糖核酸酶 I 裂解 PSDC,可释放并收集捕获的 EVs。我们的结论是,EV-FISHER 在时间(~40min 对 240min)、分离效率(74.2%对 18.1%)和分离要求(12800g 对 135000g)方面均显著优于超速离心(UC)。除了在血浆中具有稳定的性能外,EV-FISHER 还与下游单细胞 EV 流式细胞术具有出色的兼容性,能够鉴定出用于早期诊断、临床分期区分和乳腺癌队列治疗效果评估的聚糖蛋白-1(GPC-1)EVs。这项工作描绘了一种从复杂生物流体中分离 EVs 的有效策略,具有促进 EV 治疗学发展的巨大潜力。